| Financial Year |
March 31 2023 |
| Monetary Funds |
490,565,360.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,826,809.84 |
| Accounts Receivable |
618,895,558.37 |
| Advances to Suppliers |
8,245,673.74 |
| Other Receivables |
8,263,053.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,724,972.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,817,492.59 |
| Total Current Assets |
1,418,121,091.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
19,661,523.10 |
| Long-term Equity Investment |
7,376,510.17 |
| Investment Properties |
4,032,080.30 |
| Fixed Assetes |
333,132,886.01 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,335,046.45 |
| R&D expenses |
-- |
| Goodwill |
1,873,301.88 |
| Long-Term Deferred and Prepaid Expenses |
44,482,249.10 |
| Deferred Income Tax Assets |
45,778,787.76 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
468,296,687.43 |
| Total Assets |
1,886,417,778.45 |
| Short-Term Loans |
3,438,592.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,690,000.00 |
| Accounts Payable |
350,770,913.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,200,476.40 |
| Taxes Payable |
49,265,086.53 |
| Interest Payable |
-- |
| Dividend Payable |
20,512.80 |
| Other payables |
6,564,141.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,368,680.38 |
| Other Current Liabilities |
44,438,877.65 |
| Sub-Total of Current Liabilities |
485,377,804.05 |
| Long-term Loans |
146,991,117.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,862,365.97 |
| Deferred Income Tax Liabilities |
620,081.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
151,753,564.35 |
| Total Liabilities |
637,131,368.40 |
| Paid-In Capital(Or Share Stock) |
108,337,500.00 |
| Capital Surplus |
577,539,765.74 |
| Surplus Reserve |
50,458,236.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
513,010,877.25 |
| Minority Stockholder's Interest |
-3,449,772.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,252,736,182.20 |
| Owner's Equity（Stockholder's Equity） |
1,249,286,410.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,886,417,778.45 |
